BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26648079)

  • 1. An Overview of Emerging Immunotargets of Genitourinary Tumors.
    Montironi R; Santoni M; Cheng L; Lopez-Beltran A; Massari F; Matrana MR; Moch H; Scarpelli M
    Curr Drug Targets; 2016; 17(7):750-6. PubMed ID: 26648079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel immunotherapies in GU malignancies.
    Drakaki A; McDermott DF
    Curr Oncol Rep; 2013 Jun; 15(3):224-31. PubMed ID: 23519772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bibliography. Current world literature. Genitourinary systems.
    Curr Opin Oncol; 2000 May; 12(3):B104-33. PubMed ID: 10841204
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy in genitourinary malignancies.
    Wattenberg MM; Fong L; Madan RA; Gulley JL
    Curr Opin Urol; 2016 Nov; 26(6):501-7. PubMed ID: 27471994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of urinary neopterin as an immunological parameter in patients with malignant tumors of the genitourinary tract.
    Frick J; Aulitzky W; Fuchs D; Hausen A; Joos H; Reibnegger G; Wachter H
    Urol Int; 1985; 40(3):155-9. PubMed ID: 3874460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives].
    Bigot F; Bonnet C; Massard C
    Bull Cancer; 2017 Apr; 104(4):370-379. PubMed ID: 28237355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy in uropathology].
    Verkarre V; Roussel H; Granier C; Tartour E; Allory Y
    Ann Pathol; 2017 Feb; 37(1):90-100. PubMed ID: 28111042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing Natural Killer Cell Function for Genitourinary Cancers.
    Bhardwaj N; Farkas AM; Gul Z; Sfakianos JP
    Urol Clin North Am; 2020 Nov; 47(4):433-442. PubMed ID: 33008494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen in patients with urologic cancers.
    Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
    Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
    [No Abstract]   [Full Text] [Related]  

  • 10. Genitourinary cancer.
    Hudes GR; Grana G; Deshields MS; Ozols RF
    Cancer Chemother Biol Response Modif; 1992; 13():508-40. PubMed ID: 1389919
    [No Abstract]   [Full Text] [Related]  

  • 11. Genitourinary cancer.
    Hudes GR; Ozols RF; Schilder RJ
    Cancer Chemother Biol Response Modif; 1991; 12():509-48. PubMed ID: 1718377
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent advances in the use of therapeutic cancer vaccines in genitourinary malignancies.
    Surolia I; Gulley J; Madan RA
    Expert Opin Biol Ther; 2014 Dec; 14(12):1769-81. PubMed ID: 25212872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value and potential subtypes of immune activity scores in three major urological cancers.
    Shi B; Qi J
    J Cell Physiol; 2021 Apr; 236(4):2620-2630. PubMed ID: 32853461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy in genitourinary neoplasia.
    Droller MJ
    J Urol; 1985 Jan; 133(1):1-5. PubMed ID: 2578065
    [No Abstract]   [Full Text] [Related]  

  • 15. Blocking immune checkpoints in prostate, kidney, and urothelial cancer: An overview.
    Alme AK; Karir BS; Faltas BM; Drake CG
    Urol Oncol; 2016 Apr; 34(4):171-81. PubMed ID: 26923782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging immunotherapeutic strategies targeting telomerases in genitourinary tumors.
    Carrozza F; Santoni M; Piva F; Cheng L; Lopez-Beltran A; Scarpelli M; Montironi R; Battelli N; Tamberi S
    Crit Rev Oncol Hematol; 2018 Nov; 131():1-6. PubMed ID: 30293699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genitourinary cancer.
    Ozols RF; Yagoda A
    Cancer Chemother Biol Response Modif; 1990; 11():602-29. PubMed ID: 2171615
    [No Abstract]   [Full Text] [Related]  

  • 18. Genitourinary cancer.
    Ozols RF; Yagoda A
    Cancer Chemother Biol Response Modif; 1987; 9():280-302. PubMed ID: 2856337
    [No Abstract]   [Full Text] [Related]  

  • 19. Current Landscape of Immunotherapy in Genitourinary Malignancies.
    Alhalabi O; Rafei H; Bilen MA; Shah AY
    Adv Exp Med Biol; 2020; 1244():107-147. PubMed ID: 32301013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene and immune-based therapies for genitourinary malignancies: current status and future prospects.
    Zisman A; Pantuck AJ; Belldegrun A
    Isr Med Assoc J; 2000 Jan; 2(1):33-42. PubMed ID: 10892369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.